AlphaCrest Capital Management’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,553
Closed -$1.9M 755
2022
Q3
$1.9M Buy
33,553
+28,659
+586% +$1.81M 0.12% 252
2022
Q2
$297K Buy
+4,894
New +$279K 0.01% 1122
2022
Q1
Sell
-4,373
Closed -$251K 1354
2021
Q4
$251K Sell
4,373
-9,345
-68% -$517K 0.01% 1296
2021
Q3
$734K Buy
+13,718
New +$857K 0.04% 755
2021
Q1
Sell
-3,136
Closed -$217K 1264
2020
Q4
$217K Sell
3,136
-3,283
-51% -$209K 0.02% 1051
2020
Q3
$387K Buy
6,419
+2,605
+68% +$161K 0.04% 734
2020
Q2
$232K Sell
3,814
-4,993
-57% -$274K 0.04% 764
2020
Q1
$436K Sell
8,807
-2,856
-24% -$217K 0.05% 630
2019
Q4
$950K Sell
11,663
-6,037
-34% -$494K 0.08% 373
2019
Q3
$1.46M Buy
17,700
+7,400
+72% +$602K 0.09% 364
2019
Q2
$804K Buy
+10,300
New +$800K 0.07% 496

Other funds holding NHI

AlphaCrest Capital Management's NHI Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of National Health Investors (NHI) in Q4 2022, closing a stake of 33,553 shares — an estimated $1.9M sold.

AlphaCrest Capital Management first reported a position in NHI in Q2 2019 and held it in 11 quarters. The position peaked at $1.9M in Q3 2022. 233 funds tracked by Wall St. Rank hold NHI as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining National Health Investors position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 33,553 National Health Investors shares in Q4 2022, an estimated $1.9M.
  • AlphaCrest Capital Management first reported a position in National Health Investors in Q2 2019 and held it in 11 quarters.
  • AlphaCrest Capital Management's National Health Investors position peaked at $1.9M in Q3 2022.
  • 233 funds tracked by Wall St. Rank held National Health Investors as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.